"I am eager to help Microbia bring the vast promise of its exciting technology to market," said Mr. Doyle. "Microbia has a significant competitive position based on its advanced metabolic engineering innovations. Our goal is to become a leading global supplier of nutrition ingredients that deliver significant added value to our customers in the feed, food, beverage, and dietary supplement industries."
Mike Doyle brings more than 12 years of executive management experience to Microbia, including as director, human nutrition for BASF's North American business, and most recently, as president of LycoRed, Corp. in North America. While at BASF, Mr. Doyle oversaw development and marketing of vitamins, carotenoids, food and beverage polymers, and other food ingredients. At LycoRed Corp., Mr. Doyle was responsible for all operations in the North American marketplace. Mr. Doyle is also a former board member and Treasurer of the Council for Responsible Nutrition. He received a B.S. degree in marketing and industrial management from New York University, and an M.B.A. from Michigan State University.
ABOUT MICROBIA (WWW.MICROBIA-PE.COM)
Microbia is an industrial biotechnology company applying proprietary metabolic engineering to create cost-effective, renewable specialty ingredients and biomaterials. Microbia will develop and commercialize its products through direct sales and strategic alliances, including an ongoing multi-product joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Microbia's carotenoids will be the first p
Copyright©2009 Vocus, Inc.
All rights reserved